Abstract
In murine collagen-induced arthritis (CIA), self-reactive T cells can recognize peptide antigens derived from type-II collagen (CII). Activation of T cells is an important mediator of autoimmune diseases. Thus, T cells have become a focal point of study to treat autoimmune diseases. In this study, we evaluated the efficacy of recombinant MHC class II molecules in the regulation of antigen-specific T cells by using a self peptide derived from CII (CII260-274; IAGFKGEQGPKGEPG) linked to mouse I-Aq in a murine CIA model. We found that recombinant I-Aq/CII260-274 molecules could be recognized by CII-specific T cells and inhibit the same T cells in vitro. Furthermore, the development of CIA in mice was successfully prevented by in vivo injection of recombinant I-Aq/CII260-274 molecules. Thus, treatment with recombinant soluble MHC class II molecules in complex with an immunodominant self-peptide might offer a potential therapeutic for chronic inflammation in autoimmune disease such as rheumatoid arthritis.
Original language | English |
---|---|
Pages (from-to) | 331-336 |
Number of pages | 6 |
Journal | BMB reports |
Volume | 49 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2016 |
Keywords
- Collagen-induced arthritis
- Immunotherapy
- Recombinant MHC II
- Rheumatoid arthriti
- Type-II collagen
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology